Shorter TB treatment with rifapentine in Kazakhstan
Part of Infections clinical trials.
This study tests shorter treatments for tuberculosis (TB) and TB infection using the drug rifapentine. If you have TB or are at risk of developing it, this trial may help you finish treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- If you have TB, it must be a new case that can be treated with standard drugs, and you must have been treated for less than 1 month.
- If you have TB infection (without active disease), you must have had no TB treatment in the past 2 years.
- You must live in one of the four pilot regions of Kazakhstan (Almaty, Karaganda, Pavlodar, or Shymkent).
- You cannot be pregnant, breastfeeding, or have severe liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
This trial tests a shorter treatment for children with tuberculosis (TB) that is not drug-resistant. It aims to find out if a shorter regimen works as well as the standard longer one, making treatment easier for children and their families.
This study is testing whether a shorter course of TB medicine works just as well as the standard longer treatment for children with drug-susceptible tuberculosis. It aims to make treatment easier for families.
This study tests a shorter, all-oral treatment for people with Rifampicin-resistant TB. It aims to see if a new combination of drugs works well and safely over a shorter time.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.